Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1130 result(s) found, displaying 301 to 325

  • AusPAR: Upadacitinib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Upadacitinib

  • AusPAR: Crizanlizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Crizanlizumab

  • AusPAR: Satralizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Satralizumab

  • AusPAR: Sotrovimab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Sotrovimab

  • AusPAR: Ofatumumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ofatumumab

  • AusPAR: Ferric carboxymaltose

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ferric carboxymaltose

  • AusPAR: Midodrine hydrochloride

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Midodrine hydrochloride

  • AusPAR: Elasomeran

    Australian public assessment report (AusPar)
    Spikevax (elasomeran) for the prevention of COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.

  • AusPAR: BNT162b2 (mRNA)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for BNT162b2 (mRNA)

  • AusPAR: Trabectedin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Trabectedin

  • AusPAR: Ad26.COV2.S

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ad26.COV2.S

  • AusPAR: Filgotinib maleate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Filgotinib maleate

  • AusPAR: Baricitinib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Baricitinib

  • AusPAR: Durvalumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Durvalumab

  • AusPAR: Follitropin alfa

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Follitropin alfa

  • AusPAR: Mogamulizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Mogamulizumab

  • AusPAR: Olaparib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Olaparib